# The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM

> **NCT06218524** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Southern Medical University, China** · enrollment: 200 (estimated)

## Conditions studied

- Glioblastoma Multiforme

## Interventions

- **DRUG:** Haloperidol Tablets
- **DRUG:** Temozolomide

## Key facts

- **NCT ID:** NCT06218524
- **Lead sponsor:** Southern Medical University, China
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-12-01
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-07-31
- **Target enrollment:** 200 (ESTIMATED)
- **Last updated:** 2024-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06218524

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06218524, "The Effectiveness of HP and TMZ Synergism on Adult Recurrence GBM". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06218524. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*